(Q53209394)

English

Performance status, but not the hematopoietic cell transplantation comorbidity index (HCT-CI), predicts mortality at a Canadian transplant center.

scientific article published in September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

Performance status, but not the hematopoietic cell transplantation comorbidity index (HCT-CI), predicts mortality at a Canadian transplant center. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

1 reference

based on heuristic

inferred from title

author name string

R Guilfoyle

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

A Demers

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

C Bredeson

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

E Richardson

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

M Rubinger

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

D Szwajcer

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

M D Seftel

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

language of work or name

0 references

publication date

1 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

43

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

133-139

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Charlson Comorbidity Index can add prognostic information to Rapid Emergency Medicine Score as a predictor of long-term mortality

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimen.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

An integrated evaluation of socioeconomic and clinical factors in the survival from childhood acute lymphoblastic leukaemia: a study in Greece

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Influence of patients' socioeconomic status on clinical management decisions: a qualitative study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Socioeconomic inequalities and oral cancer risk: a systematic review and meta-analysis of case-control studies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Importance of performance status for treatment outcome in advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Multifocal glioblastoma multiforme: prognostic factors and patterns of progression

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Access to care, health status, and health disparities in the United States and Canada: results of a cross-national population-based survey

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Performance Status and Comorbidity Predict Transplant-Related Mortality After Allogeneic Hematopoietic Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

21 January 2018

Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

7 January 2021

based on heuristic

inferred from DOI database lookup

Charlson Index comorbidity adjustment for ischemic stroke outcome studies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

7 January 2021

based on heuristic

inferred from DOI database lookup

Adapting the Charlson Comorbidity Index for use in patients with ESRD

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

7 January 2021

based on heuristic

inferred from DOI database lookup

Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.300

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2008.300

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/18762762

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53209394&oldid=2212031017"